Tolerance and Effectiveness of C14 on HPV Infection

NCT06672653 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

HPV-induced Cancers
HPV Infections
HIV
Cervical Cancers
Trial
C14
Monoterpenoid Zinc Tetra-ascorbo-camphorate

Interventions

DRUG: The monoterpenoid zinc tetra-ascorbo-camphorate ("C14")
DRUG: Distilled water group

Sponsor

MGB Pharma